Overview

Preventive Healthcare Technologies and Services Market is poised to register a CAGR of 13% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Preventive Healthcare Technologies and Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Preventive Healthcare Technologies and Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Preventive Healthcare Technologies and Services Market:
• Abbott
• McKesson Corporation
• Scripto LLC
• Omnicell, Inc.
• Healthways, Inc.
• Alere
• Medtronic
• GlaxoSmithKline plc
• Pfizer, Inc.
• Merck & Co, Inc.
• Dilon Technologies, Inc.
• Omron Healthcare, Inc.
• Myriad Genetics, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Preventive Healthcare Technologies and Services Market Segmentation:
By Type
• Early detection and screening technologies
  o Automated screening
  o Personalized medicine
  o Other advanced screening technologies
• Chronic disease management technologies
  o Blood pressure monitors
  o Asthma monitors
  o Cardiovascular monitors
  o Glucose monitors
• Vaccines
  o Infectious Diseases Vaccine
  o Cancer Vaccine
  o Autism Vaccine
  o Allergy Vaccine
  o Other new vaccines
• Advanced technologies to reduce errors
  o Electronic prescribing
  o Clinical decision supports system
  o Smart infusion pumps
  o Computerized provider order entry system
  o Smart packaging and automated prescription formulation and dispensing

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Preventive Healthcare Technologies and Services Market By Type and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Preventive Healthcare Technologies and Services Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Preventive Healthcare Technologies and Services Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Preventive Healthcare Technologies and Services Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Preventive Healthcare Technologies and Services Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Early detection and screening technologies
       7.1.1. Automated screening
       7.1.2. Personalized medicine
       7.1.3. Other advanced screening technologies
  7.2. Chronic disease management technologies
       7.2.1. Blood pressure monitors
       7.2.2. Asthma monitors
       7.2.3. Cardiovascular monitors
       7.2.4. Glucose monitors
  7.3. Vaccines
       7.3.1. Infectious Diseases Vaccine
       7.3.2. Cancer Vaccine
       7.3.3. Autism Vaccine
       7.3.4. Allergy Vaccine
       7.3.5. Other new vaccines
  7.4. Advanced technologies to reduce errors
       7.4.1. Electronic prescribing
       7.4.2. Clinical decision supports system
       7.4.3. Smart infusion pumps
       7.4.4. Computerized provider order entry system
       7.4.5. Smart packaging and automated prescription formulation and dispensing

8. North America Preventive Healthcare Technologies and Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  8.1. Introduction
  8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       8.2.1. U.S.A
       8.2.2. Canada
       8.2.3. Mexico
  8.3. Market Size (USD Million) Forecast for North America 2022-2028

9. Latin America Preventive Healthcare Technologies and Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   9.1. Introduction
   9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         9.2.1. Brazil
         9.2.2. Venezuela
         9.2.3. Argentina
         9.2.4. Rest of Latin America
   9.3. Market Size (USD Million) Forecast for Latin America 2022-2028

10. Europe Preventive Healthcare Technologies and Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         10.2.1. Germany
         10.2.2. U.K        
         10.2.3. France
         10.2.4. Italy
         10.2.5. Spain
         10.2.6. Russia
         10.2.7. Poland
         10.2.8. Rest of Europe
   10.3. Market Size (USD Million) Forecast for Europe 2022-2028

11. Asia Pacific Preventive Healthcare Technologies and Services Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         11.2.1. Japan
         11.2.2. China
         11.2.3. India
         11.2.4. Australia and New Zealand
         11.2.5. ASEAN
         11.2.6. Rest of Asia Pacific
   11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

12. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. GCC
         12.2.2. Israel
         12.2.3. South Africa
         12.2.4. Rest of MEA
   12.3. Market Size (USD Million) Forecast for MEA 2022-2028

13. Market Share Analysis and Competitive Landscape  
   13.1. Global Landscape - Key Players, Revenue and Presence
   13.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   13.3. Global Emerging Companies
   13.4.  North America - Market Share Analysis and Key Regional Players
   13.5.  Europe - Market Share Analysis and Key Regional Players
   13.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   13.7.  Global Key Player - Growth Matrix

14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   14.1. Abbott
         14.1.1. Company Overview
         14.1.2. Product Portfolio
         14.1.3. SWOT Analysis
         14.1.4. Financial Overview
         14.1.5. Strategic Overview
   14.2. McKesson Corporation
         14.2.1. Company Overview
         14.2.2. Product Portfolio
         14.2.3. SWOT Analysis
         14.2.4. Financial Overview
         14.2.5. Strategic Overview
   14.3. Scripto LLC
         14.3.1. Company Overview
         14.3.2. Product Portfolio
         14.3.3. SWOT Analysis
         14.3.4. Financial Overview
         14.3.5. Strategic Overview
   14.4. Omnicell, Inc.
         14.4.1. Company Overview
         14.4.2. Product Portfolio
         14.4.3. SWOT Analysis
         14.4.4. Financial Overview
         14.4.5. Strategic Overview
   14.5. Healthways, Inc.
         14.5.1. Company Overview
         14.5.2. Product Portfolio
         14.5.3. SWOT Analysis
         14.5.4. Financial Overview
         14.5.5. Strategic Overview          
   14.6. Alere
         14.6.1. Company Overview
         14.6.2. Product Portfolio
         14.6.3. SWOT Analysis
         14.6.4. Financial Overview
         14.6.5. Strategic Overview      
   14.7. Medtronic
         14.7.1. Company Overview
         14.7.2. Product Portfolio
         14.7.3. SWOT Analysis
         14.7.4. Financial Overview
         14.7.5. Strategic Overview
   14.8. GlaxoSmithKline plc
         14.8.1. Company Overview
         14.8.2. Product Portfolio
         14.8.3. SWOT Analysis
         14.8.4. Financial Overview
         14.8.5. Strategic Overview
   14.9. Pfizer, Inc.
         14.9.1. Company Overview
         14.9.2. Product Portfolio
         14.9.3. SWOT Analysis
         14.9.4. Financial Overview
         14.9.5. Strategic Overview
   14.10. Merck & Co, Inc.
         14.10.1. Company Overview
         14.10.2. Product Portfolio
         14.10.3. SWOT Analysis
         14.10.4. Financial Overview
         14.10.5. Strategic Overview
   14.11.Dilon Technologies, Inc.
         14.11.1. Company Overview
         14.11.2. Product Portfolio
         14.11.3. SWOT Analysis
         14.11.4. Financial Overview
         14.11.5. Strategic Overview
   14.12.Omron Healthcare, Inc.
         14.12.1. Company Overview
         14.12.2. Product Portfolio
         14.12.3. SWOT Analysis
         14.12.4. Financial Overview
         14.12.5. Strategic Overview
   14.13.Myriad Genetics, Inc.
         14.13.1. Company Overview
         14.13.2. Product Portfolio
         14.13.3. SWOT Analysis
         14.13.4. Financial Overview
         14.13.5. Strategic Overview

15. Pre and Post COVID-19 Impact
   15.1. Positive influence on the healthcare industry
   15.2. The financial disruption of the manufacturing sector
   15.3. Impact of COVID-19 on emerging companies
   15.4. Significant mandates in the healthcare regulations initiated by administrations
   15.5. The overall economic slowdown of the developing and developed nations

16. FutureWise SME Key Takeaway Points for Client

Tables

Figures